Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (11): 703-704.
DOI: 10.19803/j.1672-8629.2019.11.15
YUWEN Lixia, KONG Yingli, YUAN Yaohui, WANG Lihua*
Received:2019-11-27
Revised:2019-11-27
Online:2019-11-20
Published:2019-11-27
CLC Number:
YUWEN Lixia, KONG Yingli, YUAN Yaohui, WANG Lihua. One Case of Severe Allergic Reaction Induced by Diclofenac Sodium Lidocaine Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(11): 703-704.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.11.15
| [1] 黄秋明. 双氯芬酸所致不良反应63例分析[J].中国药师,2009,12(1):99-101. [2] 张美霞,朱迎英.含双氯芬酸抗炎药的不良反应回顾[J].海峡药学, 2013, 25(5):294-296. [3] 吴文利,王晓旭,王基云,等.双氯芬酸钠盐酸利多卡因注射液致喉头水肿1例[J].中国药物警戒, 2017, 14(10):639-640. [4] 彭卫珍,陈华,孔令春.双氯芬酸钠致不良反应46例分析[J].医药导报, 2012, 31(3):392-394. [5] 崔艺,袁俊波. 双氯芬酸钠所致过敏反应文献概述[J].中国药物滥用防治杂志, 2016, 22(1):47-48. [6] 闫敏,吴苗苗.双氯芬酸钠栓剂致过敏性休克[J].中国误诊学杂志, 2011,11(28):6901. [7] 胡利群,方琴,苏洲.肌注双氯芬酸钠盐酸利多卡因注射液致过敏性休克1例[J].中国医药用药评价与分析, 2015,15(12):1709-1710. [8] 耿艳莉,龚云.双氯芬酸钠栓致过敏性休克1例[J].医药导报, 2008, 27(11):1333. [9] 夏敬民,彭强,陈家璇.复方双氯芬酸钠注射液过敏1例[J].药物流行病学杂志, 2002, 11(2):99. [10] 付玉芳,乙苏北,吴世凯,等.双氯芬酸钠肠溶片致严重变态反应1例[J].医药导报, 2001, 30(7):925. [11] 金怡,盛敏,褚雪文.双氯芬酸钠缓释片致严重过敏反应1例[J].中国药师, 2014, 39(10):1748. [12] 陈霞. 双氯芬酸钠栓致过敏反应[J].药物不良反应杂志,2011,13(6):393. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
